COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead
- 17 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 27 (13) , 1442-1446
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Severe Acute Respiratory Syndrome-associated Coronavirus Nucleocapsid Protein Interacts with Smad3 and Modulates Transforming Growth Factor-β SignalingJournal of Biological Chemistry, 2021
- Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort studyBone Research, 2020
- Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosisEuropean Respiratory Review, 2019
- Thin-Section Computed Tomography Manifestations During Convalescence and Long-Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS)Medical Science Monitor, 2016
- Mechanical Ventilation–associated Lung Fibrosis in Acute Respiratory Distress SyndromeAnesthesiology, 2014
- The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health statusRespirology, 2010
- SARS Coronavirus and Lung Fibrosis2009
- The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of SurvivorsChest, 2005
- Pulmonary Sequelae in Convalescent Patients after Severe Acute Respiratory Syndrome: Evaluation with Thin-Section CTRadiology, 2005
- The spectrum of pathological changes in severe acute respiratory syndrome (SARS)Histopathology, 2004